Adalimumab (40mg)
Plamumab 40 mg Injection is used in the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis,
Plamumab 40mg Injection (0.8ml Each) is given by a healthcare professional and should not be self-administered. You should use it regularly and at the same time each day to get the maximum benefit from it. Continue using it as recommended by your doctor a
1 Injection
Cipla Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Plamumab 40 mg Injection blocks the action of certain chemical messengers that are responsible for inflammation, swelling and redness associated with certain joint diseases.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Plamumab 40 mg Injection is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Plamumab 40 mg Injection is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well.
Plamumab 40 mg Injection may cause room spinning sensation and vision disturbances. This may affect your driving ability.
There is limited information available on the use of Plamumab 40 mg Injection in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Plamumab 40 mg Injection in patients with liver disease. Please consult your doctor.
